Regeneron Pharmaceuticals, Inc. director Huda Y Zoghbi sells 7,439 shares worth $7.22M
The sale reduces the insider's holding by 81%, the filing shows.
A director at Regeneron Pharmaceuticals, Inc., Huda Y Zoghbi, sold 7,439 shares of the company's stock on the open market on Nov 3. The sale, at an average of $970.46 a share, comes to $7.22 million.
The Form 4 does not tick the Rule 10b5-1 box: the sale is not reported as part of a pre-arranged trading plan. The sale reduces the insider's holding by 81%, to 1,703 shares.
Four Regeneron Pharmaceuticals, Inc. insiders sold on the open market within 14 days, a pattern known as a cluster sell. The trade was reported within two business days, as Section 16 requires.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Regeneron Pharmaceuticals, Inc. (REGN) |
|---|---|
| Insider | Huda Y Zoghbi |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 7,439 |
| Average price | $970.46 |
| Value | $7,219,274 |
| Trade date | Nov 3, 2026 |
| Filed with the SEC | Nov 5, 2026, 4:05 PM ET |
| Shares held after | 1,703 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See every transaction in this Regeneron Pharmaceuticals, Inc. filing
See earlier insider stories on Regeneron Pharmaceuticals, Inc. · See all insider activity at Regeneron Pharmaceuticals, Inc.
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
